Open AccessHepatitis B reactivation and timing for prophylaxis
Author(s) -
Nazan Tuna,
Oğuz Karabay
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i7.2263
Subject(s) - lamivudine , medicine , hepatitis b virus , hepatitis b , virology , immunology , immunotherapy , hepatitis , virus , immune system
It is known that immunotherapy and cancer chemotherapy may cause hepatitis B virus (HBV) reactivation in hepatitis B surface antigen carriers and inactive chronic hepatitis B patients. Guidelines recommend antiviral prophylaxis regardless of HBV DNA levels to prevent reactivation. We read from the article written by Liu et al that Lamivudine was given inadequate time for antiviral prophylaxis.